NEWS ROOM
- 2022.12.15Meiji Seika Pharma started the Phase III Trial of “ARCT-154” Topics
- 2022.12.01Yo Nakajima has been appointed CIO (Chief Information Officer) of Axcelead Press Release
- 2022.11.15Axcelead to Present at the 41st Annual J.P. Morgan Healthcare Conference 2023 Topics
- 2022.10.03【ARCALIS】Construction plan of mRNA therapeutics and vaccine production facility has been adopted for “Biopharmaceutical Production Base Development Project for Strengthening the Vaccine Production System” by the Ministry of Economy, Trade and Industry Press Release
- 2022.08.25Notice concerning Discussions between Meiji Seika Pharma and Arcalis, Regarding the Production and Supply of “ARCT-154” for Replicon Vaccine for COVID-19 Press Release